Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine

Immunology Letters

Volumn 107, Issue 2, 2006, Pages 131-139

  Hirano, Takashi ^a,b   Jiao, Xinan ^a   Chen, Zhong ^a   Van Waes, Carter ^a   Gu, Xin Xing ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b OITA UNIVERSITY   (Japan)

Author keywords

Intranasal immunization; Lipooligosaccharide conjugate vaccine; Nasal associated lymphoid tissue

Indexed keywords

ANTIBODY CONJUGATE; CYTOKINE; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; LIPOOLIGOSACCHARIDE TETANUS TOXOID CONJUGATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CERVICAL LYMPH NODE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HAEMOPHILUS INFLUENZAE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; INFLUENZA; INOCULATION; LUNG ALVEOLUS CELL; LYMPHOID TISSUE; MOUSE; MUCOSAL IMMUNITY; NASOPHARYNX; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; HAEMOPHILUS VACCINES; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KINETICS; LIPOPOLYSACCHARIDES; LYMPHOCYTES; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; NASAL LAVAGE FLUID; NASAL MUCOSA; NASOPHARYNX; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 33751188270     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2006.08.005     Document Type: Article

References (38)

1. Wu H.Y., Nahm M.H., Guo Y., Russell M.W., and Briles D.E. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis 175 (1997) 839-846
2. Kurono Y., Yamamoto M., Fujihashi K., Kodama S., Suzuki M., Mogi G., et al. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. J Infect Dis 180 (1999) 122-132
3. Sabirov A., Kodama S., Hirano T., et al. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media. Infect Immun 69 (2001) 2964-2971
4. Bergquist C., Lagergard T., and Holmgren J. Antibody responses in serum and lung to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxoid. APMIS 106 (1998) 800-806
5. Jakobsen H., Saeland E., Gizurarson S., Schulz D., and Jonsdottir I. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections. Infect Immun 67 (1999) 4128-4133
6. Shen X., Lagergard T., Yang Y., Lindblad M., Fredriksson M., and Holmgren J. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine. Infect Immun 68 (2000) 5749-5755
7. Baudner B.C., Balland O., Giuliani M.M., Von Hoegen P., Rappuoli R., Betbeder D., et al. Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles. Infect Immun 70 (2002) 4785-4790
8. Mariotti S., Teloni R., von Hunolstein C., Romagnoli G., Orefici G., and Nisini R. Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant. Vaccine 20 (2002) 2229-2239
9. Savirov A., and Metzger D.W. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media. Vaccine 24 (2006) 5584-5592
10. Hirano T., Hou Y., Jiao X., and Gu X.X. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx. FEMS Immunol Med Microbiol 35 (2003) 1-10
11. Jiao X., Hirano T., Hou Y., and Gu X.X. Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine. Infect Immun 70 (2002) 5982-5989
12. Bjarnarson S.P., Jakobsen H., Del Giudice G., Trannoy E., Siegrist C.A., and Jonsdottir I. The advantage of mucosal immunization for polysaccharide-specific memory responses in early life. Eur J Immunol 35 (2005) 1037-1045
13. Jakobsen H., and Jonsdottir I. Mucosal vaccination against encapsulated respiratory bacteria-new potentials for conjugate vaccines?. Scand J Immunol 58 (2003) 119-128
14. Ichimiya I., Kawauchi H., Fujiyoshi T., Tanaka T., and Mogi G. Distribution of immunocompetent cells in normal nasal mucosa: comparisons among germ-free, specific pathogen-free, and conventional mice. Ann Otol Rhinol Laryngol 100 (1991) 638-642
15. Kuper C.F., Koornstra P.J., Hameleers D.M., Biewenga J., Spit B.J., Duijvestijn A.M., et al. The role of nasopharyngeal lymphoid tissue. Immunol Today 13 (1992) 219-224
16. Spit B.J., Hendriksen E.G., Bruijntjes J.P., and Kuper C.F. Nasal lymphoid tissue in the rat. Cell Tissue Res 255 (1989) 193-198
17. Wu H.Y., and Russell M.W. Nasal lymphoid tissue, intranasal immunization and compartmentalization of the common mucosal immune system. Immunol Res 16 (1997) 187-201
18. Hou Y., Hu W.G., Hirano T., and Gu X.X. A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model. Vaccine 20 (2002) 2375-2381
19. Asanuma H., Thompson A.H., Iwasaki T., Sato Y., Inaba Y., Aizawa C., et al. Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Meth 202 (1997) 123-131
20. Wu H.Y., Nguyen H.H., and Russell M.W. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol 46 (1997) 506-513
21. Gu X.X., Tsai C.M., Ueyama T., Barenkamp S.J., Robbins J.B., and Lim D.J. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins. Infect Immun 64 (1996) 4047-4053
22. Openshaw P., Murphy E.E., Hosken N.A., Maino V., Davis K., Murphy K., et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 182 (1995) 1357-1367
23. Pala P., Hussell T., and Openshaw P.J. Flow cytometric measurement of intracellular cytokines. J Immunol Meth 243 (2000) 107-124
24. Seong S.Y., Cho N.H., Kwon I.C., and Jeong S.Y. Protective immunity of microsphere-based mucosal vaccines against lethal intranasal challenge with Streptococcus pneumoniae. Infect Immun 67 (1999) 3587-3592
25. Jakobsen H., Bjarnarson S., Del Giudice G., Moreau M., Siegrist C.A., and Jonsdottir I. Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice. Infect Immun 70 (2002) 1443-1452
26. Heritage P.L., Underdown B.J., Arsenault A.L., Snider D.P., and McDermott M.R. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am J Respir Crit Care Med 156 (1997) 1256-1262
27. Wu H.Y., Nikolova E.B., Beagley K.W., and Russell M.W. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue. Immunology 88 (1996) 493-500
28. Asanuma H., Aizawa C., Kurata T., and Tamura S. IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration. Vaccine 16 (1998) 1257-1262
29. Tamura S., Iwasaki T., Thompson A.H., Asanuma H., Chen Z., Suzuki Y., et al. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection. J Gen Virol 79 (1998) 291-299
30. Jones P.P., and Cebra J.J. Restriction of gene expression in B lymphocytes and their progeny. III. Endogenous IgA and IgM on the membranes of different plasma cell precursors. J Exp Med 140 (1974) 966-976
31. Cazac B.B., and Roes J. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13 (2000) 443-451
32. Yanagita M., Hiroi T., Kitagaki N., Hamada S., Ito H.O., Shimauchi H., et al. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J Immunol 162 (1999) 3559-3565
33. Murray P.D., McKenzie D.T., Swain S.L., and Kagnoff M.F. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol 139 (1987) 2669-2674
34. Xu-Amano J., Kiyono H., Jackson R.J., Staats H.F., Fujihashi K., Burrows P.D., et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 178 (1993) 1309-1320
35. Yamamoto M., Vancott J.L., Okahashi N., Marinaro M., Kiyono H., Fujihashi K., et al. The role of Th1 and Th2 cells for mucosal IgA responses. Ann NY Acad Sci 778 (1996) 64-71
36. Kurono Y., Suzuki M., Mogi G., Yamamoto M., Fujihashi K., McGhee J.R., et al. Effects of intranasal immunization on protective immunity against otitis media. Int J Pediatr Otorhinolaryngol 49 (1999) S227-S229
37. Robin G., Keisari Y., Slepon R., Ashkenazi S., and Cohen D. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines. Vaccine 17 (1999) 3109-3115
38. Gu X.X., Rudy S.F., Chu C., McCullagh L., Kim H.N., Chen J., et al. Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae. Vaccine 21 (2003) 2107-2114